205 related articles for article (PubMed ID: 17996684)
1. MIF tautomerase inhibitor potency of alpha,beta-unsaturated cyclic ketones.
Garai J; Molnár V; Eros D; Orfi L; Lóránd T
Int Immunopharmacol; 2007 Dec; 7(13):1741-6. PubMed ID: 17996684
[TBL] [Abstract][Full Text] [Related]
2. Ketone bodies affect the enzymatic activity of macrophage migration inhibitory factor.
Garai J; Lóránd T; Molnár V
Life Sci; 2005 Aug; 77(12):1375-80. PubMed ID: 15893774
[TBL] [Abstract][Full Text] [Related]
3. Macrophage migration inhibitory factor (MIF) tautomerase inhibitors as potential novel anti-inflammatory agents: current developments.
Garai J; Lóránd T
Curr Med Chem; 2009; 16(9):1091-114. PubMed ID: 19275614
[TBL] [Abstract][Full Text] [Related]
4. Critical modifications of the ISO-1 scaffold improve its potent inhibition of macrophage migration inhibitory factor (MIF) tautomerase activity.
Cheng KF; Al-Abed Y
Bioorg Med Chem Lett; 2006 Jul; 16(13):3376-9. PubMed ID: 16682188
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure of macrophage migration inhibitory factor complexed with (E)-2-fluoro-p-hydroxycinnamate at 1.8 A resolution: implications for enzymatic catalysis and inhibition.
Taylor AB; Johnson WH; Czerwinski RM; Li HS; Hackert ML; Whitman CP
Biochemistry; 1999 Jun; 38(23):7444-52. PubMed ID: 10360941
[TBL] [Abstract][Full Text] [Related]
6. Pro-1 of macrophage migration inhibitory factor functions as a catalytic base in the phenylpyruvate tautomerase activity.
Lubetsky JB; Swope M; Dealwis C; Blake P; Lolis E
Biochemistry; 1999 Jun; 38(22):7346-54. PubMed ID: 10353846
[TBL] [Abstract][Full Text] [Related]
7. Discovery of covalent inhibitors for MIF tautomerase via cocrystal structures with phantom hits from virtual screening.
McLean LR; Zhang Y; Li H; Li Z; Lukasczyk U; Choi YM; Han Z; Prisco J; Fordham J; Tsay JT; Reiling S; Vaz RJ; Li Y
Bioorg Med Chem Lett; 2009 Dec; 19(23):6717-20. PubMed ID: 19836948
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of the phenylpyruvate tautomerase activity of macrophage migration inhibitory factor by 2-oxo-4-phenyl-3-butynoate.
Golubkov PA; Johnson WH; Czerwinski RM; Person MD; Wang SC; Whitman CP; Hackert ML
Bioorg Chem; 2006 Aug; 34(4):183-99. PubMed ID: 16780921
[TBL] [Abstract][Full Text] [Related]
9. Macrophage migration inhibitory factor and the discovery of tautomerase inhibitors.
Orita M; Yamamoto S; Katayama N; Fujita S
Curr Pharm Des; 2002; 8(14):1297-317. PubMed ID: 12052220
[TBL] [Abstract][Full Text] [Related]
10. Plant-derived anti-inflammatory compounds affect MIF tautomerase activity.
Molnar V; Garai J
Int Immunopharmacol; 2005 May; 5(5):849-56. PubMed ID: 15778121
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of human D-dopachrome tautomerase, a homologue of macrophage migration inhibitory factor, at 1.54 A resolution.
Sugimoto H; Taniguchi M; Nakagawa A; Tanaka I; Suzuki M; Nishihira J
Biochemistry; 1999 Mar; 38(11):3268-79. PubMed ID: 10079069
[TBL] [Abstract][Full Text] [Related]
12. Antagonism of macrophage migration inhibitory factor decreases cyclophosphamide cystitis in mice.
Vera PL; Iczkowski KA; Howard DJ; Jiang L; Meyer-Siegler KL
Neurourol Urodyn; 2010 Nov; 29(8):1451-7. PubMed ID: 20127836
[TBL] [Abstract][Full Text] [Related]
13. A fluorinated analog of ISO-1 blocks the recognition and biological function of MIF and is orally efficacious in a murine model of colitis.
Dagia NM; Kamath DV; Bhatt P; Gupte RD; Dadarkar SS; Fonseca L; Agarwal G; Chetrapal-Kunwar A; Balachandran S; Srinivasan S; Bose J; Pari K; B-Rao C; Parkale SS; Gadekar PK; Rodge AH; Mandrekar N; Vishwakarma RA; Sharma S
Eur J Pharmacol; 2009 Apr; 607(1-3):201-12. PubMed ID: 19239912
[TBL] [Abstract][Full Text] [Related]
14. An integrative in silico methodology for the identification of modulators of macrophage migration inhibitory factor (MIF) tautomerase activity.
El Turk F; Fauvet B; Ouertatani-Sakouhi H; Lugari A; Betzi S; Roche P; Morelli X; Lashuel HA
Bioorg Med Chem; 2010 Jul; 18(14):5425-40. PubMed ID: 20639113
[TBL] [Abstract][Full Text] [Related]
15. Vitamin E is a MIF Inhibitor.
Hegde B; Vadnal P; Sanghavi J; Korde V; Kulkarni-Almeida AA; Dagia NM
Biochem Biophys Res Commun; 2012 Feb; 418(2):384-9. PubMed ID: 22281490
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of MIF bioactivity by rational design of pharmacological inhibitors of MIF tautomerase activity.
Dios A; Mitchell RA; Aljabari B; Lubetsky J; O'Connor K; Liao H; Senter PD; Manogue KR; Lolis E; Metz C; Bucala R; Callaway DJ; Al-Abed Y
J Med Chem; 2002 Jun; 45(12):2410-6. PubMed ID: 12036350
[TBL] [Abstract][Full Text] [Related]
17. Ellagic Acid, a Dietary Polyphenol, Inhibits Tautomerase Activity of Human Macrophage Migration Inhibitory Factor and Its Pro-inflammatory Responses in Human Peripheral Blood Mononuclear Cells.
Sarkar S; Siddiqui AA; Mazumder S; De R; Saha SJ; Banerjee C; Iqbal MS; Adhikari S; Alam A; Roy S; Bandyopadhyay U
J Agric Food Chem; 2015 May; 63(20):4988-98. PubMed ID: 25929447
[TBL] [Abstract][Full Text] [Related]
18. Novel inhibitors of macrophage migration inhibitory factor prevent cytokine-induced beta cell death.
Vujicic M; Nikolic I; Krajnovic T; Cheng KF; VanPatten S; He M; Stosic-Grujicic S; Stojanovic I; Al-Abed Y; Saksida T
Eur J Pharmacol; 2014 Oct; 740():683-9. PubMed ID: 24967533
[TBL] [Abstract][Full Text] [Related]
19. Coumarin and chromen-4-one analogues as tautomerase inhibitors of macrophage migration inhibitory factor: discovery and X-ray crystallography.
Orita M; Yamamoto S; Katayama N; Aoki M; Takayama K; Yamagiwa Y; Seki N; Suzuki H; Kurihara H; Sakashita H; Takeuchi M; Fujita S; Yamada T; Tanaka A
J Med Chem; 2001 Feb; 44(4):540-7. PubMed ID: 11170644
[TBL] [Abstract][Full Text] [Related]
20. Structure-Activity Relationships and Anti-inflammatory Activities of N-Carbamothioylformamide Analogues as MIF Tautomerase Inhibitors.
Zhang Y; Xu L; Zhang Z; Zhang Z; Zheng L; Li D; Li Y; Liu F; Yu K; Hou T; Zhen X
J Chem Inf Model; 2015 Sep; 55(9):1994-2004. PubMed ID: 26288111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
